Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 8;23(5):157.
doi: 10.1208/s12249-022-02311-y.

Gastroretentive Sustained-Release Tablets Combined with a Solid Self-Micro-Emulsifying Drug Delivery System Adsorbed onto Fujicalin®

Yoshihiro Omachi  1
Affiliations

Gastroretentive Sustained-Release Tablets Combined with a Solid Self-Micro-Emulsifying Drug Delivery System Adsorbed onto Fujicalin®

Yoshihiro Omachi. AAPS PharmSciTech. .

Abstract

Gastroretentive drug delivery systems (GRDDS) get retained in the stomach for a long time, thus facilitating the absorption of drugs in the upper gastrointestinal tract. However, drugs that are difficult to dissolve or unstable in an acidic environment are not suitable for GRDDS. The current study designs GRDDS combined with a self-micro-emulsifying drug delivery system (SMEDDS) for drugs with solubility or stability problems in the stomach. The model drug fenofibrate was formulated into the optimized liquid SMEDDS composed of 50 w/w% Capryol® PGMC, 40 w/w% Kolliphor® RH40, and 10 w/w% Transcutol® HP and solidified through adsorption on several porous adsorbents. In a dissolution medium at pH 1.2, the powdered SMEDDS using Fujicalin® dissolved quickly and achieved higher drug dissolution than other adsorbents. Based on these results, a gastroretentive bilayer tablet consisting of a drug release layer and a swelling layer was designed. The drug release layer was formulated with the powdered SMEDDS and hydroxypropyl methylcellulose (HPMC) as a release modifier. HPMC was also added to the swelling layer as a water-swellable polymer. The dissolution rate depended on the viscosity of the HPMC in the drug release layer. The time for 90% drug release was extended from 3.7 to 12.0 h by increasing the viscosity grade of HPMC from 0.1 to 100 K. Moreover, the tablet swelled and maintained a size comparable to a human pylorus diameter or more for at least 24 h. This GRDDS could apply to a broader range of drug candidates.

Keywords: Fujicalin®; Gastroretentive drug delivery system (GRDDS); Hydroxypropyl methylcellulose (HPMC); Self-micro-emulsifying drug delivery system (SMEDDS); Sustained-release.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Lopes CM, Bettencourt C, Rossi A, Buttini F, Barata P. Overview on gastroretentive drug delivery systems for improving drug bioavailability. Int J Pharm. 2016;510:144–58. https://doi.org/10.1016/j.ijpharm.2016.05.016 . - DOI - PubMed
    1. Vrettos NN, Roberts CJ, Zhu Z. Gastroretentive technologies in tandem with controlled-release strategies: a potent answer to oral drug bioavailability and patient compliance implications. Pharmaceutics. 2021;13:1591. https://doi.org/10.3390/pharmaceutics13101591 . - DOI - PubMed - PMC
    1. Rahamathulla M, Saisivam S, Gangadharappa HV. Development of valsartan floating matrix tablets using low density polypropylene foam powder: in vitro and in vivo evaluation. AAPS PharmSciTech. 2019;20:35. https://doi.org/10.1208/s12249-018-1265-z . - DOI - PubMed
    1. Vasvári G, Haimhoffer A, Horváth L, Budai I, Trencsényi G, Béresová M, et al. Development and characterization of gastroretentive solid dosage form based on melt foaming. AAPS PharmSciTech. 2019;20:290. https://doi.org/10.1208/s12249-019-1500-2 . - DOI - PubMed
    1. Nguyen TT, Hwang KM, Kim SH, Park ES. Development of novel bilayer gastroretentive tablets based on hydrophobic polymers. Int J Pharm. 2020;574: 118865. https://doi.org/10.1016/j.ijpharm.2019.118865 . - DOI - PubMed

LinkOut - more resources